Geographic Atrophy Market Driven by Rising Geriatric Population

The growing geriatric population is a major factor fueling the Geographic Atrophy Market. As life expectancy increases globally, age-related eye disorders such as geographic atrophy are becoming more common, increasing demand for long-term disease management solutions.

Market analysis of the Geographic Atrophy Market highlights strong investment in research and development activities. Healthcare providers are increasingly focusing on early detection, monitoring, and patient education to slow disease progression and improve quality of life.

FAQs

1. Which age group is most affected?
Individuals aged 60 years and above.

2. Is geographic atrophy curable?
Currently, there is no cure, but treatments aim to slow progression.

3. Does early diagnosis help?
Yes, it helps in better disease management.